Baixia Yang
Nantong University
14 Papers
20 Citations
Baixia Yang is an academic researcher from Nantong University. The author has contributed to research in topics: Medicine & Radiosensitivity. The author has an hindex of 8, co-authored 11 publications.
Chat about Author
Papers
Potential biomarkers for esophageal cancer
TL;DR: The potential biomarkers of esophageal cancer in three aspects were reviewed: Immunohistochemical markers, blood-based markers, miRNA markers and Gene expression profiling, which provided promising therapeutic targets for the diagnosis, treatment, and prognosis of esophileal cancer.
Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer
Qu Zhang,Chi Zhang,Xi Yang,Baixia Yang,Jinfeng Wang,Yahui Kang,Zhongming Wang,Defan Li,Guanhong Huang,Zhaoming Ma,Xinchen Sun,Jing Cai,Guangzhou Tao,Shengbin Dai,Weidong Mao,Jianxin Ma +15 more
TL;DR: Berberine increased radiosensitivity of prostate cancer cells and xenografts in a dose dependent manner, and this was correlated with the inhibition of HIF-1α and VEGF expression.
Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
TL;DR: It was shown that ATX improved radiosensitivity of ESCC cells and induced apoptosis and G2/M arrest via inhibiting Bcl2, CyclinB1, Cdc2, and promoting Bax expression, suggesting ATX might function as a promising radiosensitizer in EScc cells.
39
Esophageal cancer stem cells and implications for future therapeutics.
TL;DR: Targeting CSCs of esophageal cancer can be a logical strategy to treat EC, as these cells are responsible for carcinoma recurrence and chemoradiation resistance.
Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study.
TL;DR: In this article, the authors investigated the clinicopathological features and the survival outcomes of neuroendocrine prostate cancer (NEPC) patients and found that age, histologic subtype, and stage were independent prognostic factors for NEPC patients.
27